Scientists draw evidence-based blueprint for HIV treatment, prevention
Tuesday, December 1, 2015 - 13:00
in Health & Medicine
For many years, clinicians debated the best time to start antiretroviral therapy for HIV infection, with some worrying that the risks of treatment in terms of drug toxicities could outweigh the benefits of controlling the virus. In a new commentary, scientists argue that the results of three large clinical trials definitively prove that the benefits of starting ART early in infection outweigh any theoretical risk.